C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2011
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/2011
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011132171A1 Nitric oxide releasing prodrugs of therapeutic agents
10/27/2011	WO2011131605A1 Production of atorvastatin low in ether impurities
10/27/2011	WO2011131601A1 Production of atorvastatin low in lactone impurities
10/27/2011	WO2011068894A3 Novel curcumin-antibody conjugates as anti-cancer agents
10/27/2011	US20110263874 Process for Producing Cyclic Compounds
10/27/2011	US20110263870 Novel pyrrole derivatives and their synthesis
10/27/2011	US20110263819 Simplified one-pot synthesis of [18f]sfb for radiolabeling
10/27/2011	US20110263674 C-nitroso-derived nitroxyl donors
10/27/2011	US20110263673 Atropisomers of (Hydroxyalkyl) Pyrrole Derivatives
10/27/2011	US20110263604 Oxidase inhibitors and their use
10/27/2011	US20110263567 Compounds for inhibiting semicarbazide-sensitive amine oxidase (ssao) / vascular adhesion protein-1 (vap-1) and uses thereof for treatment and prevention of diseases
10/27/2011	US20110263556 New Compounds
10/27/2011	US20110263544 1-Phenylpyrrole Derivatives
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011	US20110263428 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides
10/27/2011	US20110262963 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
10/26/2011	EP2380895A1 Furanose Derivatives
10/26/2011	EP2380882A1 Salts of heterocyclic anions and their uses as ionic conductive materials
10/26/2011	EP2379686A2 A lubricating oil additive composition and method of making the same
10/26/2011	EP2379685A2 A post-treated additive composition and method of making the same
10/26/2011	EP2379501A1 Method for preparing activated esters
10/26/2011	EP2379500A1 Process for the preparation of pyrollidine-3-carboxylic acids
10/26/2011	EP2379493A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
10/26/2011	EP2181985B1 Antiviral Agent
10/26/2011	EP2142504B1 Lactam-substituted dicarboxylic acids and use thereof
10/26/2011	EP1888523B1 Cyclobutyl amine derivatives
10/26/2011	CN102227407A Hepatitis c virus inhibitors
10/26/2011	CN102227406A Preparation method of (r)-3- vinyl pyrrolidine-1- tert-butyl methanoic acid and intermediates thereof
10/26/2011	CN102227403A Process for removing by-products from n-vinylamides
10/26/2011	CN101289417B Process for preparing D-3-thioacetyl-2-methylpropionyl-L-proline
10/25/2011	US8044069 Compounds as calcium channel blockers
10/25/2011	US8044048 Derivatives of sulindac, use thereof and preparation thereof
10/25/2011	US8043786 Acid generators, sulfonic acids, sulfonyl halides, and radiation sensitive resin compositions
10/20/2011	WO2011128650A1 Intermediates useful for the synthesis of pyrrolobenzodiazepines
10/20/2011	WO2011128299A1 Process for the preparation of pyrrolines from gamma-nitroketones. use of the gamma-nitroketones as pesticidal agents
10/20/2011	WO2011128263A1 Method for producing dithiine tetracarboximides
10/20/2011	WO2011095772A3 Novel iminosugar therapeutics
10/20/2011	US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011	US20110257242 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257241 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011	US20110256549 Novel reagents for directed biomarker signal amplification
10/20/2011	US20110256457 Nonaqueous secondary battery and flame retardant for the same
10/19/2011	EP2376489A1 Alkaloid aminoester derivatives and medicinal composition thereof
10/19/2011	EP2376447A2 Dipeptidyl peptidase iv inhibitors
10/19/2011	EP1957451B1 Soft anticholinergic zwitterions
10/19/2011	EP1948596B1 Soft anticholinergic esters
10/19/2011	EP1851210B1 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
10/19/2011	CN1906161B N-sulfonyldicarboximide containing tethering compounds
10/19/2011	CN102224252A Novel compound signamycin, method for production thereof, and use thereof
10/19/2011	CN102224217A Electroluminescent device using the electroluminescent compounds
10/19/2011	CN102224139A Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/19/2011	CN102224137A Process for preparing an n-alkyllactam with improved color quality
10/19/2011	CN102224136A 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/19/2011	CN102222798A Nonaqueous secondary battery and flame retardant for the same
10/19/2011	CN102219765A Method for synthesizing chloro(bromo)alkenyl cyclocompound with iron catalyst alkynyl acetal
10/19/2011	CN102219724A Pyrrolidone compound as well as preparation method and applications thereof
10/19/2011	CN102219723A 1,2,5-triphenyl substituted pyrrole derivative with gathering induced luminescence performance as well as preparation method and application thereof
10/18/2011	US8039675 Catalysts
10/18/2011	US8039642 Pyrenyloxysulfonic acid fluorescent agents
10/18/2011	US8039507 For treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma; 7-[(3R,4R)-2-Oxo-4-((E)-3-oxo-oct-1-enyl)-pyrrolidin-3-yl]-hept-5-ynoic acid methyl ester; prostaglandin EP2 agonists
10/18/2011	US8039495 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators
10/18/2011	US8039489 Guanidine-containing compounds useful as muscarinic receptor antagonists
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039014 3′-alkoxyspirocyclopentyl-substituted tetramic and tetronic acids
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2360275C Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/13/2011	WO2011125627A1 Rare-earth metal complex
10/13/2011	US20110251403 Method for Manufacturing Hydroxyl Group Substitution Product
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251187 Heterocyclic compound
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110251119 Mixtures of itaconic acid or itaconic acid derivatives and primary amines for producing 1,3- and 1,4-alkyl methyl pyrrolidones
10/13/2011	US20110251061 Agrochemical Formulations Containing Pyrrolidone Alkylene Oxides
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/12/2011	EP2374794A1 Cyclic amine compounds
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2373620A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
10/12/2011	EP2373617A1 Mixtures of itaconic acid or itaconic acid derivatives and primary amines for producing 1,3- and 1,4-alkyl methyl pyrrolidones
10/12/2011	EP2373609A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
10/12/2011	EP2229356B1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
10/12/2011	EP2107052B1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
10/12/2011	EP1695955B1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	EP1366022B1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
10/12/2011	CN102216267A Method for purifying aminoacetylpyrrolidinecarbonitrile derivative and salt thereof
10/12/2011	CN102216260A Amino acid derivative
10/12/2011	CN102212086A Biphenyl phosphine-oxazoline ligand-iridium complex as well as preparation and application methods thereof
10/12/2011	CN101591284B Method for preparing chlorfenapyr and analog thereof
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034949 Pyrrolidine compound and a process for preparing the same
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	CA2514191C Compound inhibiting dipeptidyl peptidase iv

1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 404